» Articles » PMID: 39330890

Suitable Mouse Model to Study Dynamics of West Nile Virus Infection in Mosquitoes

Abstract

West Nile Virus (WNV) poses a significant global public health threat as a mosquito-borne pathogen. While laboratory mouse models have historically played a crucial role in understanding virus biology, recent research has focused on utilizing immunocompromised models to study arboviruses like dengue and Zika viruses, particularly their interactions with mosquitoes. However, there has been a shortage of suitable mouse models for investigating WNV and St. Louis encephalitis virus interactions with their primary vectors, spp. mosquitoes. Here, we establish the AG129 mouse (IFN α/β/γ R) as an effective vertebrate model for examining mosquito-WNV interactions. Following intraperitoneal injection, AG129 mice exhibited transient viremia lasting several days, peaking on the second or third day post-infection, which is sufficient to infect mosquitoes during a blood meal. We also observed WNV replication in the midgut and dissemination to other tissues, including the fat body, in infected mosquitoes. Notably, infectious virions were present in the saliva of a viremic AG129 mouse 16 days post-exposure, indicating successful transmission capacity. These findings highlight the utility of AG129 mice for studying vector competence and WNV-mosquito interactions.

Citing Articles

Vector Competence of from São Tomé and Príncipe for West Nile Virus Transmission.

Marme R, Tomaz F, Sousa C, Pinto J, Lanzaro G, Parreira R Microorganisms. 2024; 12(10).

PMID: 39458347 PMC: 11509904. DOI: 10.3390/microorganisms12102038.

References
1.
Wanasen N, Nussenzveig R, Champagne D, Soong L, Higgs S . Differential modulation of murine host immune response by salivary gland extracts from the mosquitoes Aedes aegypti and Culex quinquefasciatus. Med Vet Entomol. 2004; 18(2):191-9. DOI: 10.1111/j.1365-2915.2004.00498.x. View

2.
Patel H, Sander B, Nelder M . Long-term sequelae of West Nile virus-related illness: a systematic review. Lancet Infect Dis. 2015; 15(8):951-9. DOI: 10.1016/S1473-3099(15)00134-6. View

3.
Meier K, Gardner C, Khoretonenko M, Klimstra W, Ryman K . A mouse model for studying viscerotropic disease caused by yellow fever virus infection. PLoS Pathog. 2009; 5(10):e1000614. PMC: 2749449. DOI: 10.1371/journal.ppat.1000614. View

4.
Rajamanonmani R, Nkenfou C, Clancy P, Yau Y, Shochat S, Sukupolvi-Petty S . On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes. J Gen Virol. 2009; 90(Pt 4):799-809. PMC: 2889437. DOI: 10.1099/vir.0.006874-0. View

5.
Campos R, Preciado-Llanes L, Azar S, Kim Y, Brandon O, Lopez-Camacho C . Adenoviral-Vectored Mayaro and Chikungunya Virus Vaccine Candidates Afford Partial Cross-Protection From Lethal Challenge in A129 Mouse Model. Front Immunol. 2020; 11:591885. PMC: 7672187. DOI: 10.3389/fimmu.2020.591885. View